KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Liabilities (2017 - 2025)

Neogenomics' Other Non-Current Liabilities history spans 9 years, with the latest figure at $12.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 2.52% year-over-year to $12.1 million; the TTM value through Dec 2025 reached $12.1 million, up 2.52%, while the annual FY2025 figure was $12.1 million, 2.52% up from the prior year.
  • Other Non-Current Liabilities reached $12.1 million in Q4 2025 per NEO's latest filing, up from $12.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $14.4 million in Q3 2021 to a low of $3.7 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $12.0 million, with a median of $13.0 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: dropped 12.47% in 2021, then surged 281.47% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $14.0 million in 2021, then fell by 6.9% to $13.1 million in 2022, then dropped by 0.16% to $13.0 million in 2023, then dropped by 9.68% to $11.8 million in 2024, then increased by 2.52% to $12.1 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Other Non-Current Liabilities are $12.1 million (Q4 2025), $12.0 million (Q3 2025), and $12.1 million (Q2 2025).